WellTheory is a virtual care platform providing autoimmune and inflammatory conditions care services.
WellTheory has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
WellTheory's investors include General Catalyst, Accel, Samsung NEXT, Lux Capital, BoxGroup.
WellTheory is headquartered in Atherton, United States.
WellTheory is a virtual care platform providing autoimmune and inflammatory conditions care services.
WellTheory is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WellTheory — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/welltheory-atherton. Accessed October 21, 2026.
VCBacked. (2025). WellTheory — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/welltheory-atherton
{{cite web |title=WellTheory — Funding & Investors |url=https://www.vcbacked.co/company/welltheory-atherton |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated